Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
28.10
+0.10 (0.36%)
At close: Feb 20, 2026, 4:00 PM EST
28.01
-0.09 (-0.32%)
After-hours: Feb 20, 2026, 5:09 PM EST
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.83 billion as of February 20, 2026. Its market cap has increased by 92.00% in one year.
Market Cap
1.83B
Enterprise Value
1.44B
1-Year Change
92.00%
Ranking
Category
Stock Price
$28.10
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.83B, an increase of 186.65%. That is a compound annual growth rate of 23.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 1.83B | 1.26% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 1.96B |
| Vericel | 1.93B |
| Aurinia Pharmaceuticals | 1.90B |
| Olema Pharmaceuticals | 1.89B |
| Nuvation Bio | 1.87B |
| Galecto | 1.81B |
| RAPT Therapeutics | 1.79B |
| Recursion Pharmaceuticals | 1.78B |